Skip to main content
. 2023 Jul 3;2023:3844069. doi: 10.1155/2023/3844069

Table 1.

Clinical features of patients with pulmonary embolism (PE) in situ and PE not in situ.

Variable PE in situ (n = 51) PE not in situ (n = 13) P value
n (%) n (%)
Sex
 Male 32 (64.0) 12 (92.3) 0.086
 Female 18 (36.0) 1 (7.7)
Age, mean ± SD 58.70 ± 12.73 55.0 ± 14.38 0.367
Distribution
 Central 1 (2.0) 0 (0) 0.794
 Peripheral 35 (68.6) 9 (69.2)
 Both 15 (29.4) 4 (30.8)
COVID-19
 Active COVID-19 41 (80.4) 9 (69.2) 0.457
 Post COVID-19 10 (19.6) 4 (30.8)
Superadded bacterial infection 5 (9.8) 0 (0) 0.574
Thrombosis elsewhere 2 (3.9) 2 (15.4) 0.181
Fever 18 (35.3) 4 (30.8) 1.000
Runny nose 2 (3.9) 1 (7.7) 0.500
Cough 21 (41.2) 4 (30.8) 0.544
SOB 35 (68.6) 12 (92.3) 0.157
Headache 1 (2.0) 0 (0) 1.000
Vomiting 1 (2.0) 0 (0) 1.000
Muscle ache/body ache 4 (7.8) 1 (7.7) 1.000
Malaise 2 (3.9) 1 (7.7) 0.500
Lethargy 3 (5.9) 0 (0) 1.000
Pharyngeal discomfort/pain 1 (2.0) 0 (0) 1.000
Chest pain 3 (5.9) 2 (15.4) 0.266
Pleuritic chest pain 1 (2.0) 0 (0) 1.000
Abdominal pain 1 (2.0) 1 (7.7) 0.368
Diarrhea 1 (2.0) 1 (7.7) 0.368
Hemoptysis 1 (2.0) 1 (7.7) 0.368
SYNCOPE 1 (2.0) 0 (0) 1.000
Anorexia 2 (3.9) 0 (0) 1.000
eGFR
 Normal 25 (54.3) 8 (61.5) 0.757
 Abnormal 21 (45.7) 5 (38.5)
CRP
 Normal 6 (20.0) 3 (37.5) 0.363
 Abnormal 24 (80.0) 5 (62.5)
D-dimer
 Normal 1 (7.1) 2 (33.3) 0.202
 Abnormal 13 (92.9) 4 (66.7)
Platelets
 Normal 33 (71.7) 10 (83.3) 0.712
 Abnormal 13 (28.3) 2 (16.7)
DM 22 (43.1) 3 (23.1) 0.220
IHD 7 (13.7) 0 (0) 0.328
DLP 7 (13.7) 2 (15.4) 1.000
CKD 6 (11.8) 1 (7.7) 1.000
Obesity 2 (3.9) 2 (15.4) 0.181
Cirrhosis 4 (7.8) 0 (0) 0.574
Asthma/ILD/COPD/bronchiectasis 2 (3.9) 1 (7.7) 0.500
Smoking 4 (7.8) 0 (0) 0.574
HTN 16 (31.4) 3 (23.1) 0.739
Cancer 1 (2.0) 0 (0) 1.000
ICU 7 (13.7) 2 (15.4) 1.000
Intubation 5 (9.8) 2 (15.4) 0.623
Expired 18 (35.3) 3 (23.1) 0.518